Baird lowered the firm’s price target on Alcon (ALC) to $90 from $98 and keeps an Outperform rating on the shares. The firm updated its model following results where it conviction took a hit but they still see a path for improvements.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALC:
- Alcon price target lowered to $70 from $82 at Stifel
- Alcon Q1 2026 Sales Rise 10% as New Eye-Care Products Power Growth and $1.5 Billion Buyback
- Analyst Reiterates Sell on Execution and Valuation Risks, Trims Price Target to CHF 55 Amid Competitive Pressures
- Alcon price target lowered to $87 from $92 at BTIG
- William Blair med tech analyst holds an analyst/industry conference call